친수성 카테터 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 소재별, 환자별, 사이즈별, 용도별, 지역별, 부문별 예측(2026-2033년)

Hydrophilic Catheters Market Summary

The global hydrophilic catheters market size was valued at USD 1.75 billion in 2025 and is projected to reach USD 2.89 billion by 2033, growing at a CAGR of 6.50% from 2026 to 2033. The industry is driven by the rising prevalence of urinary disorders, including urinary incontinence, neurogenic bladder, and urinary retention, which require intermittent catheterization for effective bladder management.

In addition, the growing aging population and increasing awareness of infection prevention are driving the adoption of hydrophilic-coated catheters, which reduce friction and improve patient comfort during catheterization. The increasing prevalence of urinary disorders is a key driver of the market. Conditions such as urinary retention, neurogenic bladder, spinal cord injuries, and benign prostatic hyperplasia are becoming more common, particularly among aging populations. Hydrophilic catheters are widely used for intermittent catheterization as they reduce friction, improve patient comfort, and lower the risk of urinary tract infections. As the number of patients requiring long-term bladder management increases, the demand for hydrophilic catheters continues to grow.

The rising incidence of spinal cord disorders and injuries increases the number of patients experiencing neurogenic bladder dysfunction, which often requires intermittent catheterization for effective bladder management. Hydrophilic catheters are widely preferred in these cases as they reduce friction and discomfort, thereby driving demand in the market.

Global Hydrophilic Catheters Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hydrophilic catheters market report on the basis of type, material, patient, size, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Water-Activated Hydrophilic Catheter
• Pre-Activated Hydrophilic Catheter
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• PVC Catheter
• Silicone Catheter
• Thermoplastic Polyurethane (TPU) Catheter
• Others
• Patient Outlook (Revenue, USD Million, 2021 - 2033)
• Male Hydrophilic Catheter
• Female Hydrophilic Catheter
• Pediatric Hydrophilic Catheter
• Size Outlook (Revenue, USD Million, 2021 - 2033)
• 6 Fr
• 8 Fr
• 10 Fr
• 12 Fr
• 14 Fr
• 16 Fr
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Home Care Settings
• Hospitals
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Type
  • 1.1.2. Material
  • 1.1.3. Patient
  • 1.1.4. Size
  • 1.1.5. End Use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Hydrophilic Catheters Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing prevalence of urinary disorders
    • 3.2.1.2. Rising incidence of neurological diseases and spinal cord injuries
    • 3.2.1.3. Higher awareness of catheter-associated urinary tract infections (CAUTIs)
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost compared to conventional catheters
    • 3.2.2.2. Risk of catheter-associated complications
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing adoption of home healthcare
    • 3.2.3.2. Technological advancements in catheter coatings
    • 3.2.3.3. Increasing focus on infection prevention technologies
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Patient compliance and proper usage
    • 3.2.4.2. Complex regulatory and quality requirements
• 3.3. Hydrophilic Catheters Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Hydrophilic Catheters Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Hydrophilic Catheters Market: Type Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Hydrophilic Catheters Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.3.1. Water-Activated Hydrophilic Catheter
    • 4.3.1.1. Water-activated hydrophilic catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Pre-Activated Hydrophilic Catheter
    • 4.3.2.1. Pre-activated hydrophilic catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hydrophilic Catheters Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Hydrophilic Catheters Market: Material Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Hydrophilic Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 5.3.1. PVC Catheter
    • 5.3.1.1. PVC catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Silicone Catheter
    • 5.3.2.1. Silicone catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Thermoplastic polyurethane (TPU) Catheter
    • 5.3.3.1. Thermoplastic polyurethane (TPU) catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hydrophilic Catheters Market: Patient Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Hydrophilic Catheters Market: Patient Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Hydrophilic Catheters Market Size & Trend Analysis, by Patient, 2021 to 2033 (USD Million)
  • 6.3.1. Male Hydrophilic Catheter
    • 6.3.1.1. Male hydrophilic catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Female Hydrophilic Catheter
    • 6.3.2.1. Female hydrophilic catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Pediatric Hydrophilic Catheter
    • 6.3.3.1. Pediatric hydrophilic catheter market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Hydrophilic Catheters Market: Size Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Hydrophilic Catheters Market: Size Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Hydrophilic Catheters Market Size & Trend Analysis, by Size, 2021 to 2033 (USD Million)
  • 7.3.1. 6 Fr
    • 7.3.1.1. 6 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. 8 Fr
    • 7.3.2.1. 8 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. 10 Fr
    • 7.3.3.1. 10 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. 12 Fr
    • 7.3.4.1. 12 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.5. 14 Fr
    • 7.3.5.1. 14 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.6. 16 Fr
    • 7.3.6.1. 16 Fr market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Hydrophilic Catheters Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Hydrophilic Catheters Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 8.3. Global Hydrophilic Catheters Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 8.3.1. Home Care Settings
    • 8.3.1.1. Home care settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. Hospitals
    • 8.3.2.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Hydrophilic Catheters Market: Regional Estimates & Trend Analysis by Type, Material, Patient, Size and End Use

• 9.1. Regional Dashboard
• 9.2. Market Size and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. UK hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. Germany hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. France hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Italy hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Spain hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Denmark hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Competitive scenario
    • 9.4.9.3. Regulatory framework
    • 9.4.9.4. Reimbursement scenario
    • 9.4.9.5. Norway hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. China hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Japan hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. India hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. South Korea hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Australia hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Reimbursement scenario
    • 9.5.7.5. Thailand hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Brazil hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Argentina hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. Middle East and Africa
  • 9.7.1. Middle East and Africa hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. South Africa hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. Saudi Arabia hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. UAE hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Kuwait hydrophilic catheters market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis, 2025
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Product Launches
  • 10.5.5. Research And Development
  • 10.5.6. Company Profiles
  • 10.5.7. Coloplast Corp
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. BD
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Teleflex Incorporated
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Hollister Incorporated
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. Convatec
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Wellspect HealthCare, a Dentsply Sirona Company
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product Benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. Cook
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product Benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. Medtronic
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product Benchmarking
    • 10.5.14.4. Strategic initiatives
  • 10.5.15. HR HealthCare
    • 10.5.15.1. Company overview
    • 10.5.15.2. Financial performance
    • 10.5.15.3. Product Benchmarking
    • 10.5.15.4. Strategic initiatives
  • 10.5.16. Johnson & Johnson
    • 10.5.16.1. Company overview
    • 10.5.16.2. Financial performance
    • 10.5.16.3. Product Benchmarking
    • 10.5.16.4. Strategic initiatives
  • 10.5.17. B. Braun SE
    • 10.5.17.1. Company overview
    • 10.5.17.2. Financial performance
    • 10.5.17.3. Product Benchmarking
    • 10.5.17.4. Strategic initiatives